Noncommunicable diseases (NCDs) are significant health problems worldwide and in Thailand. Dyslipidemia is an important modifiable risk factor of atherosclerotic disease, which increases the risk of vascular complications in T2DM patients. It is defined by abnormal lipid profiles, which are elevated cholesterol or triglyceride levels or reduced high-density lipoprotein levels. The results can be applied for proper management of T2DM patients and determine the associated factors to prevent complications, especially in primary health care units, which tend to have a higher prevalence of dyslipidemia. A cross-sectional study was conducted from the health registry of type 2 diabetic patients in Bangkhla hospital, Chachoengsao province, during 2016-2020 to investigate the prevalence and associated factors of dyslipidemia among T2DM patients. Adjusted odds ratio and 95% confidential intervals were calculated to determine associated factors. In a total of 3,017 diabetic patients who participated in this study, the prevalence of dyslipidemia was 78.06%. The factors associated with dyslipidemia were female sex (aOR: 2.69, 95% CI: 1.673-4.290), BMI ≥23 kg/m2 (aOR: 2.80, 95% CI: 1.497-5.236), HbA1C ≥7% (aOR: 1.66, 95% CI: 1.083-2.538), history of smoking (aOR: 4.46, 95% CI: 1.710-11.648), hypertension (aOR: 2.28, 95% CI: 1.481-3.501) and diabetic nephropathy (aOR: 7.13, 95% CI: 1.719-29.538). The prevalence of dyslipidemia among T2DM patients in Bangkhla hospital differed from the prevalence in Thai patients but was lower than in most primary care units. The associated factors were female sex, overweight, HbA1C ≥7%, smoking history, hypertension, and diabetic nephropathy. Our findings may help raise awareness of dyslipidemia in diabetic patients in healthcare providers and awareness in the patient self. The proper management and good plan for the chronic disease may help reduce the prevalence of dyslipidemia and following complications. Regular follow-up, proper advice, and encouraging patients to behavioral changes, especially modifiable smoking and weight control, would improve disease control and reduce the risk of vascular complications.
